Doximity Inc. (NYSE:DOCS) saw a 13.71% jump in its stock price on Friday, closing at $66.58 per share. The company reported a net income of $53.3 million in the first quarter of fiscal year 2026, a 28% increase from the same period last year, with revenues growing by 15% to $145.9 million. For the full fiscal year 2026, Doximity is targeting revenues of $628 million to $636 million, a 10-11.5% growth from the previous year. They also completed a $63 million merger with AI-powered platform Pathway Medical Inc., known for its high clinical accuracy.

Read more at Yahoo Finance: Doximity (DOCS) Soars 14% on Strong Earnings, Merger with AI-Powered Platform